semaglutide obesity phase 3 In the OASIS 4 trial, once-daily oral at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or OBESITY PIPELINE LOOKS PROMISING :

This side effect is generally transient but should be monitored if: You experience palpitations Theres a noticeable, sustained increase over time Its advisable to have regular cardiac assessments while on GLP-1 medication, especially if you have underlying heart conditions

If you want a deeper look at the prescribing process, how to get prescribed semaglutide for weight loss walks through the next steps

These incremental adjustments help balance efficacy with tolerability, allowing the body to adapt before reaching higher doses

Research shows that patients consuming less than 30 grams of fat per day experience significantly fewer gastrointestinal complaints while on GLP-1 therapy

Keep an eye on your pet during the entire treatment and reach out to your veterinarian if you observe any symptoms or side effects that seem unusual to your pet

The results showed that many participants experienced a noticeable decrease in back pain, alongside significant weight loss